Mark Latymer
Impact in
-
- Pain Management and Opioid Use
Papers in
-
- Biosimilars and Bioanalytical Methods 8
- Oncology 4
- CAR-T cell therapy research 2
- Co-authors
- Bruce Parsons (3 shared papers)Michael G. Serpell (2 shared papers)Andrew G Clair (2 shared papers)Rainer Freynhagen (1 shared paper)Birol Emir (1 shared paper)Ed Whalen (1 shared paper)Pere Gascón (2 shared papers)Iris Dotan (1 shared paper)
- Journals
- Advances in Therapy (4 papers)Expert Opinion on Biological Therapy (2 papers)Pain Practice (2 papers)Journal of Clinical Oncology (1 paper)Future Oncology (1 paper)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Mark Latymer
16 papers receiving 304 citations
Peers
Comparison fields: 5 of 61
- Anesthesiology and Pain Medicine 21
- Family Practice 6
- Immunology 69
- Physiology 69
- Oncology 64
Countries citing papers authored by Mark Latymer
This map shows the geographic impact of Mark Latymer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Latymer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Latymer more than expected).
Fields of papers citing papers by Mark Latymer
This network shows the impact of papers produced by Mark Latymer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Latymer. The network helps show where Mark Latymer may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Latymer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 75 | |
| 2 | 2021 | 60 | |
| 3 | 2018 | 45 | |
| 4 | 2020 | 27 | |
| 5 | 2017 | 24 | |
| 6 | 2023 | 19 | |
| 7 | 2018 | 16 | |
| 8 | 2018 | 15 | |
| 9 | 2016 | 13 | |
| 10 | 2024 | 7 | |
| 11 | 2024 | 6 | |
| 12 | 2024 | 4 | |
| 13 | 2023 | 2 | |
| 14 | 2024 | 2 | |
| 15 | 2023 | 1 | |
| 16 | 2024 | 1 |
About Mark Latymer
Mark Latymer is a scholar working on Immunology, Oncology, Physiology, Pediatrics, Perinatology and Child Health and Family Practice, having authored 16 papers that have together received 317 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (8 papers), Pain Mechanisms and Treatments (3 papers), CAR-T cell therapy research (2 papers), Pharmaceutical studies and practices (2 papers), Statistical Methods in Clinical Trials (1 paper), Dialysis and Renal Disease Management (1 paper), Intramuscular injections and effects (1 paper) and Botulinum Toxin and Related Neurological Disorders (1 paper). The work is most often cited by research in Anesthesiology and Pain Medicine (21 citations), Family Practice (6 citations), Immunology (69 citations), Physiology (69 citations) and Oncology (64 citations). Mark Latymer has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Bruce Parsons, Michael G. Serpell, Andrew G Clair, Rainer Freynhagen, Birol Emir, Ed Whalen, Pere Gascón, Iris Dotan, Irene Modesto and Giuseppe Curigliano. Their work appears in journals such as Advances in Therapy, Expert Opinion on Biological Therapy, Pain Practice, Journal of Clinical Oncology and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.